GNRC vs RIGL · P/E 82, rev $1.17B vs P/E 9.1, rev $137.5M
Generac Holdings Inc (GNRC) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
Generac Holdings Inc (GNRC) is a specialty industrial machinery company listed on US.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported GNRC revenue for 2026-06-30 was $1.17B. Net income was $143.2M. Revenue was up 10.8% from 2026-03-31 to 2026-06-30. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
Latest reported RIGL revenue for 2026-06-30 was $137.5M. Net income was $25.9M. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
GNRC currently screens at market cap $15.40B and trailing P/E 82.0. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the GNRC and RIGL stock pages for the full models.
Not investment advice.